# New lung cancer clinical trials, last 30 days: 33 (2026)

Updated November 19, 2026.

33 new trials for lung cancer were first posted on ClinicalTrials.gov in the 30 days from October 20, 2026 to November 18, 2026, as read on November 19, 2026.

## The full list

New lung cancer clinical trials, last 30 days: 33 rows for $5, first posted from October 20, 2026 to November 18, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 5 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/new/lung-neoplasms

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 33
- Recruiting or not yet: 25
- Read on: November 19, 2026

## Trials

The 25 newest of 33, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 18, 2026 | NCT07947121 | A Study of Risvutatug Rezetecan in Combination With Atezolizumab in Participants With Extensive Stage Small Cell Lung Cancer... | GlaxoSmithKline | Phase 3 | Not yet recruiting | Lung Neoplasm | 700 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07947121) |
| November 18, 2026 | NCT07947043 | Exploratory Clinical Study of Autologous Tumor-Infiltrating Lymphocytes (TIL) Injection | Tongji Hospital | Phase 1 | Recruiting | Recurrent or Metastatic Lung Cancer or Cervical Cancer | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07947043) |
| November 18, 2026 | NCT07946848 | Phase 2 Study to Evaluate Dose Optimization and Anti-tumor Activity of Atebimetinib in Participants With Advanced or Metastatic NSCLC. | Immuneering Corporation | Phase 2 | Not yet recruiting | NSCLC (Advanced Non-small Cell Lung Cancer), Non-Squamous Non Small Cell Lung Cancer, Metastatic Non-Small Lung Cell... | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946848) |
| November 18, 2026 | NCT07944469 | Cryoablation Versus Standard Nerve Block for Pain Control After Lung Surgery | University Medical Centre Maribor | Not applicable | Enrolling by invitation | Postoperative Pain After Thoracic Surgery, Lung Cancer (Suspected or Confirmed) | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07944469) |
| November 17, 2026 | NCT07942090 | Role of 68Ga-FAPI PET/CT in Patients in Whom 18F-FDG PET/CT Has Been Found to be Questionable or Inconclusive Due to Oncological Pathology | IRCCS Azienda Ospedaliero-Universitaria di Bologna | Not applicable | Enrolling by invitation | Lung Cancer Diagnosis, Head and Neck Cancer (H&N), Breast Cancer, Ovarian Cancer | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07942090) |
| November 17, 2026 | NCT07941128 | Pragmatic AI-Assisted Lung Cancer Translational Study | Sir Run Run Shaw Hospital | Not applicable | Recruiting | Lung Cancer, Artificial Intelligence (AI), Large Language Model | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07941128) |
| November 17, 2026 | NCT07940881 | A Multicenter, Open-label, Phase 1/1b, Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of SI-B037 in Solid Tumors | SystImmune Inc. | Phase 1 | Recruiting | Locally Advanced /Metastatic Solid Tumors, Locally Advanced / Metastatic Solid Tumors, First in Human, Metastatic Solid... | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07940881) |
| November 16, 2026 | NCT07938385 | Characterisation of Immunological and Molecular Changes Evolving in Patients Undergoing Radiotherapy (CHIMERA) | Royal Marsden NHS Foundation Trust | Observational | Recruiting | Impact of the Immune Cell Repertoire on the Therapeutic Index of Radiotherapy, The Need for Serum Markers of... | 94 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07938385) |
| November 13, 2026 | NCT07936578 | Clinical Study of Ivonescimab Combined With Concurrent Chemoradiotherapy in the Treatment of Advanced Non-small Cell Lung Cancer | Guizhou Medical University | Phase 2 | Not yet recruiting | Concurrent Chemoradiotherapy, Immunotherapy, Lung Cancer (NSCLC) | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07936578) |
| November 10, 2026 | NCT07928154 | MyPatientPal+: A Smartphone App and a Provider Dashboard to Manage Patient Care While on Treatment | Barbara Ann Karmanos Cancer Institute | Not applicable | Not yet recruiting | Breast Cancer, Gastrointestinal Cancer, Lung Cancer (Diagnosis), Prostate Cancer (Diagnosis), Head and Neck Cancer... | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07928154) |
| November 9, 2026 | NCT07926542 | Dexmedetomidine as an add-on Sedative for Endobronchial Ultrasound | Centro Hospitalar de Lisboa Central | Not applicable | Completed | Conscious Sedation, Lung Neoplasms, Lymphadenopathy (Mediastinal) | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07926542) |
| November 4, 2026 | NCT07915193 | Application of Generative Artificial Intelligence in Perioperative Personalized Rehabilitation for Older Adults With Lung Cancer | Peking University Cancer Hospital & Institute | Not applicable | Enrolling by invitation | Lung Neoplasms | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07915193) |
| November 4, 2026 | NCT07914881 | A Study to Screen for Lung Cancer in High-risk Individuals Who Have Never Smoked Using Low-dose Computed Tomography (LDCT). | AstraZeneca | Observational | Not yet recruiting | Lung Cancer, Thoracic Tumors | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07914881) |
| November 3, 2026 | NCT07913256 | The Impact of Rheumatoid Arthritis Treatments on the Modulation of Extracellular Vesicles and Other Biomarkers Involved in the Development... | University Hospital, Limoges | Observational | Not yet recruiting | Rheumatoid Arthritis (RA), Lung Neoplasms | 136 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07913256) |
| November 3, 2026 | NCT07912190 | ePRO in Advanced Lung Cancer: Emotional Distress, Symptom Burden, Brain Metastasis | Qian Chu | Observational | Recruiting | Lung Cancer, Brain Metastasis, Patient Reported Outcome | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07912190) |
| November 2, 2026 | NCT07911267 | Development and Utilization of an Integrated Clinical Genomic Database | Samsung Medical Center | Observational | Recruiting | Gastric Cancer, Colorectal Cancer, Lung Cancer (NSCLC), Liver Cancer, Pancreatic Cancer | 118,750 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07911267) |
| November 2, 2026 | NCT07910942 | A Phase 1 Trial of KAN-001 With Pembrolizumab, With or Without Chemotherapy, in Participants With PD-L1-Positive Non-Small Cell Lung Cancer | Kanvas Biosciences | Phase 1 | Not yet recruiting | Non-Small Cell Lung Cancer | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07910942) |
| November 2, 2026 | NCT07909343 | Patient Needs and Preferences for NSCL Cancer Treatment Monitoring | European Institute of Oncology | Observational | Recruiting | Lung Cancer (NSCLC) | 35 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07909343) |
| October 30, 2026 | NCT07906626 | Snakehead Fish Extract and Curcumin Co-Supplementation in Advanced Lung Cancer on Inflammation, Nutritional Status, and Quality of Life | Universitas Sumatera Utara | Not applicable | Completed | Lung Cancer (NSCLC) | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07906626) |
| October 29, 2026 | NCT07903415 | A Study to Learn About the Study Medicine Called PF-08098488 in People With Advanced Solid Tumors. | Pfizer | Phase 1 | Recruiting | Pancreatic Ductal Adenocarcinoma, Esophageal Cancer, Carcinoma, Non-Small-Cell Lung (NSCLC), Gastric Carcinoma... | 280 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07903415) |
| October 29, 2026 | NCT07902921 | STAR0602 With Nivolumab in Non Small Cell Lung Cancer and in Metastatic Castrate-Resistant Prostate Cancer, and STAR0602 Alone in Thymic... | National Cancer Institute (NCI) | Phase 1/2 | Not yet recruiting | NSCLC, Non-Small Cell Lung Cancer, Lung Cancer, Prostate Cancer, Thymic Epithelial Tumors, TETs, Thymic Carcinomas... | 67 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07902921) |
| October 27, 2026 | NCT07898241 | Using an Artificial Intelligence Software Tool (iSeg) During Radiation Treatment Planning for Patients With Lung Tumors | Northwestern University | Not applicable | Not yet recruiting | Lung Carcinoma, Lung Non-Small Cell Carcinoma, Metastatic Malignant Neoplasm in the Lung | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07898241) |
| October 27, 2026 | NCT07897734 | TNG462-C103: Study to Evaluate the Safety, Tolerability, and Antitumor Activity of Vopimetostat in Combination With ERAS-0015 in PDAC and... | Tango Therapeutics, Inc. | Phase 1/2 | Not yet recruiting | PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, NSCLC, RAS Mutation, MTAP Deletion, Lung Cancer, Pancreatic Cancer... | 188 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07897734) |
| October 26, 2026 | NCT07895277 | Longitudinal AI-Assisted Management of Indeterminate Pulmonary Nodules | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Not applicable | Recruiting | Pulmonary Nodules, Lung Neoplasms | 6,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07895277) |
| October 26, 2026 | NCT07895147 | Clinical Application of Artificial Intelligence Methods in Diagnostic Imaging of Pulmonary Nodules | Shanghai East Hospital | Observational | Active not recruiting | Pulmonary Nodules, Lung Neoplasms, Lung Diseases | 10,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07895147) |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 1 |
| Phase 1 | 4 |
| Phase 1/2 | 2 |
| Phase 2 | 3 |
| Phase 3 | 1 |
| Not applicable | 12 |
| Observational | 10 |

## Sponsors posting most

| Sponsor | Trials |
| --- | --- |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 3 |
| [GlaxoSmithKline](https://specstream.ai/data/clinical-trials/company/glaxosmithkline) | 1 |
| Tongji Hospital | 1 |
| Immuneering Corporation | 1 |
| University Medical Centre Maribor | 1 |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 1 |
| Sir Run Run Shaw Hospital | 1 |
| SystImmune Inc. | 1 |
| Royal Marsden NHS Foundation Trust | 1 |
| Guizhou Medical University | 1 |
| Barbara Ann Karmanos Cancer Institute | 1 |
| Centro Hospitalar de Lisboa Central | 1 |
| Peking University Cancer Hospital & Institute | 1 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 1 |
| University Hospital, Limoges | 1 |
| Qian Chu | 1 |
| Samsung Medical Center | 1 |
| Kanvas Biosciences | 1 |
| European Institute of Oncology | 1 |
| Universitas Sumatera Utara | 1 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 1 |
| National Cancer Institute (NCI) | 1 |
| Northwestern University | 1 |
| Tango Therapeutics, Inc. | 1 |
| Shanghai East Hospital | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Investment management firms in the United States](https://specstream.ai/data/businesses/investment-management-firms/united-states)
- [Fertilizer stores in the United States](https://specstream.ai/data/businesses/fertilizer-stores/united-states)
- [Community health centers in the United States](https://specstream.ai/data/businesses/community-health-centers/united-states)
- [B2B oil and gas extraction companies in the United States](https://specstream.ai/data/businesses/b2b-oil-and-gas-extraction-companies/united-states)
- [Vegetarian restaurants in the United States](https://specstream.ai/data/businesses/vegetarian-restaurants/united-states)
- [Salad bars in the United States](https://specstream.ai/data/businesses/salad-bars/united-states)
